View drug registration information details.


ItemsRegistration information
ID135
No135
Brand NameECOZOLE-400
IngredientsALBENDAZOLE USP 400 MG
Dosage FormCHEWABLE TABLET
Primary PackagingALU-PVC BLISTER
StorageSTORE IN A COOL, DRY AND DARK PLACE
Shelf Life3 YEARS
Pack SizeBOX OF 50 X 1 X 1'S
Dispensing Category
ATC Classification
Pharmaceutical ClassANTHELMINTIC
IndicationsTREATMENT OF PARENCHYMAL NEUROCYSTICERCOSIS DUE TO ACTIVE LESIONS CAUSED BY LARVAL FORMS OF THE PORK TAPEWORM, TAENIA SOLIUM. TREATMENT OF CYSTIC HYDATID DISEASE OF THE LIVER, LUNG, AND PERITONEUM CAUSED BY THE LARVAL FORM OF THE DOG TAPEWORM, ECHINOCOCCUS GRANULOSUS.
ContraindicationsPATIENT WITH HEPATIC DISEASE OR BILIARY TRACT DISEASE, PATEINT WITH BEING TREATED FOR NEUROCYSTICERCOSIS SHOULD RECEIVE APPROPRIATE CORTICOSTEROIDTHERAPY AND ANTICONVULSANT THERAPY, PATIENTS WITH HEPATIC DISEASE, INCREASED INTRACRANIAL PRESSURE, SEIZURE
Side EffectsNAUSEA, VOMITING, FITS, PROBLEM WITH YOUR VISION, DARKER URINE OR PALLERSTOOLS, YELLOW OF THE SKIN OR WHITES OF THE EYES, DIZZINESS
Unit Price
EDL Yes
DescriptionORANGE COLORED, CAPSULE SHAPED, BICONVEX, UNCOATED CHEWABLE TABLET, BREAKLINE ON ONE SIDE, PLAIN ON OTHER SIDE
Note
License OwnerASA LAO SOLE COMPANY LIMITED
ManufacturerIMPULSE PHARMA PVT.LTD
CountryINDIA
Import Registration NoKD/641 (FORM 25)
Import Registration Date2020-07-18
ActivityCERTIFICATE RELEASED
Applied Date2021-12-23
FDD Registration No03 I 5423/23
FDD Registration Date2023-03-31
Expiry Date2026-03-30

Back to drug list